SOLULINK BIOSCIENCES — Department of Health and Human Services SBIR Phase II: Our multiplex IHC assays are aimed to more accurately detect basal-like breast cancer asso
SOLULINK BIOSCIENCES — SBIR Phase II award from Department of Health and Human Services.
- Amount
- $998,116
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase II
- NAICS
- —
- Place of performance
- CA
- Period
- —
Description
Our multiplex IHC assays are aimed to more accurately detect basal-like breast cancer associated iwth lower disease-free survival and overall survival. The goal is to develop an automated assay by incorporating our assay into commercially available automated instruments that stain, scan and analyze the sample.